Pediatric multiple sclerosis: developments in timely diagnosis and prognostication

References

• Fadda G, Armangue T, Hacohen Y, et al. Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care. Lancet Neurol. 2021;20(2):136–149.
   PubMed Web of Science ®Google Scholar
• Renoux C, Vukusic S, Mikaeloff Y, et al., Natural history of multiple sclerosis with childhood onset. N Engl J Med. 2007;356(25):2603–2613.
   PubMed Web of Science ®Google Scholar
• Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain. 2004;127(Pt 9):1942–1947.
   PubMed Web of Science ®Google Scholar
• Chabas D, Castillo-Trivino T, Mowry EM, et al. Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype? Neurology. 2008;71(14):1090–1093.
   PubMed Web of Science ®Google Scholar
• Abdel-Mannan O, Cortese R, Wassmer E, et al. Primary progressive multiple sclerosis presenting under the age of 18 years: fact or fiction? Mult Scler. 2021;27(2):309–314.
   PubMedGoogle Scholar
• McKay KA, Hillert J, Manouchehrinia A. Long-term disability progression of pediatric-onset multiple sclerosis. Neurology. 2019;92(24):e2764–e2773.
   PubMed Web of Science ®Google Scholar
• Waubant E, Chabas D, Okuda DT, et al. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol. 2009;66(8):967–971.
   PubMed Web of Science ®Google Scholar
• Belman AL, Krupp LB, Olsen CS, et al. Characteristics of children and adolescents with multiple sclerosis. Pediatrics. 2016;138(1). https://doi.org/10.1542/peds.2016-0120.
   Google Scholar
• Chitnis T, Glanz B, Jaffin S, et al. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler. 2009;15(5):627–631.
   PubMed Web of Science ®Google Scholar
• McKay KA, Manouchehrinia A, Berrigan L, et al. Long-term cognitive outcomes in patients with pediatric-onset vs adult-onset multiple sclerosis. JAMA Neurol. 2019;76(9):1028–1034.
   PubMed Web of Science ®Google Scholar
• Amato MP, Krupp LB, Charvet LE, et al. Pediatric multiple sclerosis: cognition and mood. Neurology. 2016;87(9 Suppl 2):S82–87.
   PubMed Web of Science ®Google Scholar
• Krysko KM, Graves JS, Rensel M, et al. Real-world effectiveness of initial disease-modifying therapies in pediatric multiple sclerosis. Ann Neurol. 2020;88(1):42–55.
   PubMed Web of Science ®Google Scholar
• Baroncini D, Simone M, Iaffaldano P, et al. Risk of persistent disability in patients with pediatric-onset multiple sclerosis. JAMA Neurol. 2021;78(6):726–735.
   PubMed Web of Science ®Google Scholar
• Bar-Or A, Hintzen RQ, Dale RC, et al. Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases. Neurology. 2016;87(9 Suppl 2):S12–19.
   PubMed Web of Science ®Google Scholar
• Chitnis T, Aaen G, Belman A, et al. Improved relapse recovery in paediatric compared to adult multiple sclerosis. Brain. 2020;143(9):2733–2741.
   PubMedGoogle Scholar
• Filippi M, Bruck W, Chard D, et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 2019;18(2):198–210.
   PubMed Web of Science ®Google Scholar
• Goldschmidt T, Antel J, Konig FB, et al. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology. 2009;72(22):1914–1921.
   PubMed Web of Science ®Google Scholar
• Albert M, Antel J, Bruck W, et al. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol. 2007;17(2):129–138.
   PubMed Web of Science ®Google Scholar
• Pfeifenbring S, Bunyan RF, Metz I, et al. Extensive acute axonal damage in pediatric multiple sclerosis lesions. Ann Neurol. 2015;77(4):655–667.
   PubMed Web of Science ®Google Scholar
• Yeh EA, Weinstock-Guttman B, Ramanathan M, et al. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain. 2009;132(Pt 12):3392–3400.
   PubMed Web of Science ®Google Scholar
• Ghassemi R, Antel SB, Narayanan S, et al. Lesion distribution in children with clinically isolated syndromes. Ann Neurol. 2008;63(3):401–405.
   PubMed Web of Science ®Google Scholar
• Verhey LH, Signori A, Arnold DL, et al. Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials. Neurology. 2013;81(14):1215–1221.
   PubMed Web of Science ®Google Scholar
• Ghassemi R, Narayanan S, Banwell B, et al. Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis. PLoS One. 2014;9(2):e85741.
   PubMed Web of Science ®Google Scholar
• Paus T. Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci. 2005;9(2):60–68.
   PubMed Web of Science ®Google Scholar
• De Meo E, Filippi M, Trojano M, et al., Comparing natural history of early and late onset pediatric multiple sclerosis. Ann Neurol. 2022;91(4):483–495.
   PubMed Web of Science ®Google Scholar
• Longoni G, Brown RA, MomayyezSiahkal P, et al. White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders. Brain. 2017;140(5):1300–1315.
   PubMedGoogle Scholar
• Vishwas MS, Healy BC, Pienaar R, et al. Diffusion tensor analysis of pediatric multiple sclerosis and clinically isolated syndromes. AJNR Am J Neuroradiol. 2013;34(2):417–423.
   PubMed Web of Science ®Google Scholar
• Margoni M, Villani U, Finos L, et al. Neurite orientation dispersion and density imaging discloses early changes in the normal-appearing white matter in paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry. 2022;93(3):332–334.
   PubMed Web of Science ®Google Scholar
• Akbar N, Giorgio A, Till C, et al. Alterations in functional and structural connectivity in pediatric-onset multiple sclerosis. PLoS One. 2016;11(1):e0145906.
   PubMed Web of Science ®Google Scholar
• Rocca MA, Sonkin M, Copetti M, et al. Diffusion tensor magnetic resonance imaging in very early onset pediatric multiple sclerosis. Mult Scler. 2016;22(5):620–627.
   PubMed Web of Science ®Google Scholar
• Lebel C, Walker L, Leemans A, et al. Microstructural maturation of the human brain from childhood to adulthood. Neuroimage. 2008;40(3):1044–1055.
   PubMed Web of Science ®Google Scholar
• Rocca MA, De Meo E, Amato MP, et al. Cognitive impairment in paediatric multiple sclerosis patients is not related to cortical lesions. Mult Scler. 2015;21(7):956–959.
   PubMed Web of Science ®Google Scholar
• Absinta M, Rocca MA, Moiola L, et al. Cortical lesions in children with multiple sclerosis. Neurology. 2011;76(10):910–913.
   PubMed Web of Science ®Google Scholar
• Calabrese M, Seppi D, Romualdi C, et al. Gray matter pathology in MS: a 3-year longitudinal study in a pediatric population. AJNR Am J Neuroradiol. 2012;33(8):1507–1511.
   PubMed Web of Science ®Google Scholar
• Fadda G, Brown RA, Magliozzi R, et al., A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis. Ann Neurol. 2019;85(3):340–351.
   PubMed Web of Science ®Google Scholar
• De Meo E, Meani A, Moiola L, et al., Dynamic gray matter volume changes in pediatric multiple sclerosis: a 3.5 year MRI study. Neurology. 2019;92(15):e1709–e1723.
   PubMedGoogle Scholar
• De Meo E, Storelli L, Moiola L, et al. In vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology. Brain. 2021;144(1):186–197.
   PubMedGoogle Scholar
• Bonacchi R, Meani A, Pagani E, et al., Association of age at onset with gray matter volume and white matter microstructural abnormalities in people with multiple sclerosis. Neurology. 2021;97(20):e2007–e2019.
   PubMed Web of Science ®Google Scholar
• Weier K, Till C, Fonov V, et al. Contribution of the cerebellum to cognitive performance in children and adolescents with multiple sclerosis. Mult Scler. 2016;22(5):599–607.
   PubMed Web of Science ®Google Scholar
• Aubert-Broche B, Fonov V, Narayanan S, et al. Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth. Neurology. 2014;83(23):2140–2146.
   PubMed Web of Science ®Google Scholar
• Tomassini V, Matthews PM, Thompson AJ, et al. Neuroplasticity and functional recovery in multiple sclerosis. Nat Rev Neurol. 2012;8(11):635–646.
   PubMed Web of Science ®Google Scholar
• Gruchot J, Weyers V, Gottle P, et al. The molecular basis for remyelination failure in multiple sclerosis. Cells. 2019;8(8):825.
   Web of Science ®Google Scholar
• Ghassemi R, Brown R, Banwell B, et al. Canadian pediatric demyelinating disease study g. quantitative measurement of tissue damage and recovery within new T2w lesions in pediatric- and adult-onset multiple sclerosis. Mult Scler. 2015;21(6):718–725.
   PubMed Web of Science ®Google Scholar
• Brown RA, Narayanan S, Banwell B, et al. Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients. Neuroimage Clin. 2014;6:237–242.
   PubMed Web of Science ®Google Scholar
• Kolb B, Gibb R. Brain plasticity and behaviour in the developing brain. J Can Acad Child Adolesc Psychiatry. 2011;20(4):265–276.
   PubMedGoogle Scholar
• Barlow-Krelina E, Turner GR, Akbar N, et al. Enhanced recruitment during executive control processing in cognitively preserved patients with pediatric-onset MS. J Int Neuropsychol Soc. 2019;25(4):432–442.
   PubMed Web of Science ®Google Scholar
• Rocca MA, Valsasina P, Absinta M, et al. Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis. Hum Brain Mapp. 2014;35(8):4180–4192.
   PubMed Web of Science ®Google Scholar
• De Meo E, Moiola L, Ghezzi A, et al. MRI substrates of sustained attention system and cognitive impairment in pediatric MS patients. Neurology. 2017;89(12):1265–1273.
   PubMed Web of Science ®Google Scholar
• Rocca MA, Absinta M, Ghezzi A, et al. Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients? Hum Brain Mapp. 2009;30(9):2844–2851.
   PubMed Web of Science ®Google Scholar
• Rocca MA, Absinta M, Moiola L, et al. Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing-remitting multiple sclerosis. Radiology. 2010;254(2):541–550.
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–173.
   PubMed Web of Science ®Google Scholar
• Hacohen Y, Brownlee W, Mankad K, et al. Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort. Mult Scler. 2020;26(11):1372–1380.
   PubMed Web of Science ®Google Scholar
• Wong YYM, de Mol CL, van der Vuurst de Vries RM, et al. Real-world validation of the 2017 McDonald criteria for pediatric MS. Neurol Neuroimmunol Neuroinflamm. 2019;6(2):e528.
   PubMed Web of Science ®Google Scholar
• Fadda G, Brown RA, Longoni G, et al., MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study. Lancet Child Adolesc Health. 2018;2(3):191–204.
   PubMedGoogle Scholar
• Rostasy K, Mader S, Schanda K, et al. Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol. 2012;69(6):752–756.
   PubMedGoogle Scholar
• Hacohen Y, Absoud M, Deiva K, et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm. 2015;2(2):e81.
   PubMedGoogle Scholar
• Hacohen Y, Mankad K, Chong WK, et al. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children. Neurology. 2017;89(3):269–278.
   PubMed Web of Science ®Google Scholar
• Verhey LH, Branson HM, Shroff MM, et al. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol. 2011;10(12):1065–1073.
   PubMed Web of Science ®Google Scholar
• Mikaeloff Y, Suissa S, Vallee L, et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr. 2004;144(2):246–252. hazard ratio [HR]=0.23 [95% confidence interval, CI=0.10-0.56]; and 0.59 [95% CI=0.33-1.07]), whereas age at onset ≥ 10 years and the presence of an optic nerve lesion on MRI at onset increased the risk of a second clinical attack (HR=1.67 [95% CI=1.04-2.67] and 2.59 [95% CI=1.27-5.29], respectively.
   PubMed Web of Science ®Google Scholar
• Iaffaldano P, Simone M, Lucisano G, et al. Prognostic indicators in pediatric clinically isolated syndrome. Ann Neurol. 2017;81(5):729–739. [95% CI=1.06-1.55]; and HR=1.42 [95% CI=1.10-1.84]), whereas exposure to disease modifying therapies was protective (HR=0.75 [95% CI=0.60-0.95]). The presence of oligoclonal bands was not predictive of time to a second attack.
   PubMed Web of Science ®Google Scholar
• Heussinger N, Kontopantelis E, Gburek-Augustat J, et al. Oligoclonal bands predict multiple sclerosis in children with optic neuritis. Ann Neurol. 2015;77(6):1076–1082.
   PubMed Web of Science ®Google Scholar
• van der Vuurst de Vries RM, Wong YYM, Mescheriakova JY, et al. High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome. Mult Scler. 2019;25(7):958–967.
   PubMed Web of Science ®Google Scholar
• van der Vuurst de Vries RM, van Pelt ED, Mescheriakova JY, et al. Disease course after clinically isolated syndrome in children versus adults: a prospective cohort study. Eur J Neurol. 2017;24(2):315–321.
   PubMed Web of Science ®Google Scholar
• Boiko A, Vorobeychik G, Paty D, et al., University of British Columbia MSCN. Early onset multiple sclerosis: a longitudinal study. Neurology. 2002;59(7):1006–1010.
   PubMed Web of Science ®Google Scholar
• De Meo E, Bonacchi R, Moiola L, et al., Early predictors of 9-year disability in pediatric multiple sclerosis. Ann Neurol. 2021;89(5):1011–1022.
   PubMed Web of Science ®Google Scholar
• Pinhas-Hamiel O, Sarova-Pinhas I, Achiron A. Multiple sclerosis in childhood and adolescence: clinical features and management. Paediatr Drugs. 2001;3(5):329–336.
   PubMedGoogle Scholar
• Neuteboom RF, Boon M, Catsman Berrevoets CE, et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology. 2008;71(13):967–973.
   PubMed Web of Science ®Google Scholar
• Mikaeloff Y, Caridade G, Assi S, et al. Prognostic factors for early severity in a childhood multiple sclerosis cohort. Pediatrics. 2006;118(3):1133–1139.
   PubMed Web of Science ®Google Scholar
• Akhtar S, Alroughani R, Ahmed SF, et al. Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in Kuwait. Mult Scler. 2016;22(8):1086–1093.
   PubMed Web of Science ®Google Scholar
• Pascual-Leone A, Amedi A, Fregni F, et al. The plastic human brain cortex. Annu Rev Neurosci. 2005;28(1):377–401.
   PubMedGoogle Scholar
• Zatorre RJ, Fields RD, Johansen-Berg H. Plasticity in gray and white: neuroimaging changes in brain structure during learning. Nat Neurosci. 2012;15(4):528–536.
   PubMed Web of Science ®Google Scholar
• Margoni M, Rinaldi F, Perini P, et al. Therapy of pediatric-onset multiple sclerosis: state of the art, challenges, and opportunities. Front Neurol. 2021;12:676095.
   PubMed Web of Science ®Google Scholar
• Zipoli V, Goretti B, Hakiki B, et al. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler. 2010;16(1):62–67.
   PubMed Web of Science ®Google Scholar
• Carotenuto A, Moccia M, Costabile T, et al. Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis. Sci Rep. 2019;9(1):18074.
   PubMed Web of Science ®Google Scholar
• Wattjes MP, Ciccarelli O, Reich DS, et al. MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021;20(8):653–670.
   PubMed Web of Science ®Google Scholar